<p>Gynuity is pleased to announce the publication of our new resource for clinicians and women’s health advocates: Misoprostol for Treatment of Incomplete Abortion: An Introductory Guidebook. Misoprostol has many advantages in low-resource settings – it is inexpensive, widely available, thermostable, and offers a low-tech, non-invasive method of uterine evacuation. Based on current scientific evidence, the guidebook offers detailed information about misoprostol for this indication including:</p>

<ul>

<li>Efficacy, safety and acceptability;</li>

<li>Eligibility criteria and precautions;</li>

<li>Dosing, timing and routes of administration;</li>

<li>Visit schedule and management of complications;</li>

<li>Counseling and information provision;</li>

<li>Integration of misoprostol into existing <span>PAC</span> services.</li>

</ul>

<ul>

</ul>

<p> </p>

<p>In April, 2009, the World Health Organization announced the addition of misoprostol to its Model List of Essential Medicines based on its proven safety and efficacy for the treatment of incomplete abortion and miscarriage. The recommendation was made by an expert committee that evaluated available evidence, including numerous randomized comparative clinical trials and several guidelines developed by professional associations for this indication.</p>